Walk 31, 2014 — GlaxoSmithKline (GSK) Shopper Healthcare has deliberately reviewed all of its nonprescription weight loss drug alli from retailers in the Joined together States and Puerto Rico, the company announced on Walk 27.
GSK says clients have detailed that bottles of alli they obtained over the counter in retail stores contained tablets and capsules that were not alli. The company says it believes the bottles may have been altered with.
Alli is a turquoise blue capsule with a dull blue band imprinted with the content “60 Orlistat.” GSK says a “range of tablets and capsules of different shapes and colors” were detailed to be found inside bottles.
Moreover, some bottles inside the outer carton were lost names and had tamper-evident seals that were not bona fide. Alli is packaged in a labeled bottle that has an inward thwart seal imprinted with the words “Sealed for Your Assurance.”
“We have gotten reports of about 20 bottles acquired by 12 buyers in 7 states: Alabama, Florida, Louisiana, Mississippi, New York, North Carolina, and Texas. We have had no reports of genuine side impacts,” Deborah Bolding, senior outside communications supervisor of GSK Buyer Healthcare, tells Medscape Medical News by e-mail.
The recall will drag alli from store racks in 40,000 retail outlets over the U.S. and Puerto Rico, she says.
In a shopper alert issued March 26, GSK said a few bottles bearing the taking after part numbers and close dates on the carton have been detailed containing products other than alli:
February 28, 2016
February 28, 2016
September 30, 2015
January 31, 2016
April 30, 2016
“Security is our to begin with need and we are inquiring retailers and drug stores to expel all alli from their shelves quickly,” Colin Mackenzie, president of GSK Customer Healthcare North America, says in a articulation.
GSK is conducting an examination and is working with the FDA. “We are committed to finding out what happened and to doing everything possible to prevent future issues with alli,” Mackenzie says.
GSK is exhorting buyers who have obtained alli not to utilize it if they are “unsure or concerned” almost the genuineness of the product. Instead, they are inquired to call GSK at 800-671-2554 for further informational. In case anyone has taken a questionable item, they ought to contact their doctor, the company prompts.
More data is accessible at www.myalli.com.